Opposite Effects of FGF and BMP-4 on Embryonic Blood Formation: Roles of PV.1 and GATA-2  by Xu, Ren-He et al.
i
p
1
Developmental Biology 208, 352–361 (1999)
Article ID dbio.1999.9205, available online at http://www.idealibrary.com onOpposite Effects of FGF and BMP-4 on Embryonic
Blood Formation: Roles of PV.1 and GATA-21
Ren-He Xu,* Katherine Tidman Ault,*,† Jaebong Kim,‡,§ Mae-Ja Park,¶
Yoo-Seok Hwang,¶ Ying Peng,‡ Dvora Sredni,| and Hsiang-fu Kung‡,**,2
*Intramural Research Support Program, SAIC Frederick, National Cancer Institute–Frederick
Cancer Research and Development Center, Frederick, Maryland 21702; †Laboratory of
Molecular Genetics, National Institute of Child Health and Human Development, National
Institutes of Health, Bethesda, Maryland 20892; ‡Laboratory of Biochemical Physiology,
Division of Basic Sciences, National Cancer Institute, Frederick, Maryland 21702; §Department
of Biochemistry, College of Medicine, Hallym University, Chun-Cheon, Korea; ¶Department of
Anatomy, School of Medicine, Kyungpook National University, Taegu 700-422, Korea;
\Interdisciplinary Department, Bar Ilan University, Ramat Gan, Israel 52900; and **Institute
of Molecular Biology, University of Hong Kong, Hong Kong
In adult vertebrates, fibroblast growth factor (FGF) synergizes with many hematopoietic cytokines to stimulate the
proliferation of hematopoietic progenitors. In vertebrate development, the FGF signaling pathway is important in the
formation of some derivatives of ventroposterior mesoderm. However, the function of FGF in the specification of the
embryonic erythropoietic lineage has remained unclear. Here we address the role of FGF in the specification of the
erythropoietic lineage in the Xenopus embryo. We report that ventral injection of embryonic FGF (eFGF) mRNA at as little
as 10 pg at the four-cell stage suppresses ventral blood island (VBI) formation, whereas expression of the dominant negative
form of the FGF receptor in the lateral mesoderm, where physiologically no blood tissue is formed, results in a dramatic
expansion of the VBI. Similar results were observed in isolated ventral marginal zones and animal caps. Bone morphogenetic
protein-4 (BMP-4) is known to induce erythropoiesis in the Xenopus embryo. Therefore, we examined how the BMP-4 and
FGF signaling pathways might interact in the decision of ventral mesoderm to form blood. We observed that eFGF inhibits
BMP-4-induced erythropoiesis by differentially regulating expression of the BMP-4 downstream effectors GATA-2 and PV.1.
GATA-2, which stimulates erythropoiesis, is suppressed by FGF. PV.1, which we demonstrate to inhibit blood develop-
ment, is enhanced by FGF. Additionally, PV.1 and GATA-2 negatively regulate transcription of each other. Thus, BMP-4
nduces two transcription factors which have opposing effects on blood development. The FGF and BMP-4 signaling
athways interact to regulate the specification of the erythropoietic lineage. © 1999 Academic Press
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Vertebrate blood cell development involves the induction
of ventral mesoderm and the subsequent proliferation and
differentiation of a subset of ventral mesodermal cells to
form erythropoietic progenitors (Zon et al., 1991). However,
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352ow specification of the erythropoietic lineage from ventral
esoderm occurs is only partially understood. In Xenopus,
he initial induction of mesoderm occurs as early as the
2-cell stage, with signals emanating from dorsal vegetal
ells inducing dorsal mesoderm and from ventral vegetal
ells inducing ventral mesoderm (Nieuwkoop, 1969a,b).
esoderm is further patterned during gastrulation by op-
osing dorsalizing and ventralizing signals which regional-
ze the mesoderm into zones of notochord, somite, lateral
late, and ventral blood island (VBI) (Dale et al., 1987).
Mesodermal patterning appears to require an intact bone
orphogenetic protein (BMP) signaling pathway. Ventral
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353Effects of FGF and BMP-4 on Blood Formationmesoderm is induced by BMP-4 (Dale et al., 1992; Jones et
al., 1992; Moon et al., 1992) and ventral expression of a
dominant negative BMP receptor, dominant negative
BMP-4 ligand, or antisense BMP-4 mRNA converts ventral
mesoderm to dorsal mesoderm, resulting in the formation
of a secondary axis (Suzuki et al., 1994; Maeno et al., 1994;
Graff et al., 1994; Steinbeisser et al., 1995). Therefore an
active BMP signal is required to produce ventral mesoderm,
and the formation of dorsal mesoderm involves suppression
of the BMP-4 signaling pathway.
Dosch et al. (1997) has observed that increasing levels of
BMP-4 signaling generate increasingly ventral derivatives of
mesoderm. BMP-4 is therefore thought to act as a morpho-
gen whose graded activity is regulated by the antagonizing
action of dorsalizing molecules such as noggin, chordin, and
follistatin (Smith et al., 1992; Sasai et al., 1994; Fainsod et
al., 1997). Noggin (Zimmerman et al., 1996; Holley et al.,
1996) and chordin (Piccolo et al., 1996) both bind BMP-2/4
in the extracellular space and thus are thought to regulate
BMP signaling levels by interfering with their receptor
binding. Follistatin has also been reported to interact with
BMP-4 directly in vitro (Fainsod et al., 1997) and to form a
omplex with BMPs and their receptors (Iemura et al.,
998). In this model of mesodermal patterning, the region of
ighest BMP signaling generates the erythropoietic lineage.
ndeed it has been demonstrated that injection of mRNA
ncoding BMP-4 results in substantial globin expression in
he whole embryo except in the most dorsal dome (Maeno
t al., 1996). Ventral expression of a dominant negative
MP receptor completely blocks the VBI formation (Suzuki
t al., 1994; Maeno et al., 1994; Graff et al., 1994).
Several closely related homeobox genes as well as a
umber of GATA-binding factors have been shown to
ediate the patterning effects of BMP-4 on the mesoderm
nd ectoderm (Zon et al., 1991; Zhang and Evans, 1994,
996; Walmsley et al., 1994; Kelley et al., 1994; Gawantka
t al., 1995; Ault et al., 1996, 1997; Onichtchouk et al.,
996; Schmidt et al., 1996; Ladher et al., 1996; Xu et al.,
997; Maeda et al., 1997; Suzuki et al., 1997). However only
ATA-1 and GATA-2 have been reported to mediate the
timulating effect of BMP-4 on erythropoiesis (Zon et al.,
991; Walmsley et al., 1994; Zhang and Evans, 1994, 1996;
elley et al., 1994; Maeno et al., 1996; Xu et al., 1997). For
he majority of homeobox genes functioning downstream of
MP-4, little is known of their effects on the decision of
entral mesoderm to form blood. However, the effects of
wo transcription factors (Xom and Msx.1) on globin expres-
sion have been studied. Whereas Xom has been observed to
have no effect on globin expression (Ladher et al., 1996),
Msx.1 inhibits expression of globin (Maeda et al., 1997).
The roles of the other ventralizing transcription factors in
erythropoiesis remain to be assessed.
In addition to BMP-4, the FGF signaling pathway has also
been demonstrated to be crucial in the formation of some
derivatives of posterior and ventral mesoderm (Amaya et
Copyright © 1999 by Academic Press. All rightal., 1994). Two members of FGF family, basic (bFGF) and
embryonic (eFGF) FGF, are known to be expressed mater-
nally and hence are present at the stage of Xenopus meso-
derm induction, implicating these growth factors in the
specification and patterning of the mesoderm (Kimelman
and Kirschner, 1987; Amaya et al., 1994). eFGF has not been
identified as the amphibian homolog of any of the mamma-
lian FGFs reported so far. However, it is clearly related
(70%) to both human kFGF (FGF-4) and FGF-6 if the
divergent 70–80 N-terminal amino acids are left out of the
comparison (Issacs et al., 1992). Both bFGF and eFGF have
been shown to induce mesoderm of similar nature with the
latter having more potent effect. However, the role of FGF
signaling in embryonic erythropoiesis has remained un-
clear. bFGF has been reported to be able to induce “blood-
like cells” in animal pole explants; however, globin expres-
sion in response to bFGF has not been demonstrated (Green
et al., 1990).
Here we report that ventral expression of eFGF sup-
presses the VBI formation, whereas expression of a domi-
nant negative form of the FGF receptor (XFD; Amaya et al.,
1994) in the lateral marginal zone (LMZ) results in a
dramatic expansion of the VBI. Furthermore, expression of
FGF or XFD is sufficient to similarly modulate erythroid
development in isolated ventral marginal zones (VMZs) and
animal cap ectoderm. We show that FGF inhibits BMP-4-
induced erythropoiesis by suppressing GATA-2 and enhanc-
ing PV.1 transcript levels. We further demonstrate PV.1 to
be a potent inhibitor of blood development and a dominant
interfering construct of PV.1 to significantly enhance eryth-
ropoiesis.
MATERIALS AND METHODS
DNA and RNA preparation. A dominant interfering form of
PV.1, PV.1-EnR, was constructed using PCR strategy fusing the
N-domain of PV.1 with the repressor domain of the Drosophila
engrailed (Badiani et al., 1994). PV.1-EnR was proven to inhibit
V.1 activity in the Xenopus embryo (Kim et al., unpublished data).
ll cDNA constructs encoding b-galactosidase (b-gal), XFD
(Amaya et al., 1994), eFGF (Kimelman and Kirschner, 1987),
BMP-4, PV.1 (Ault et al., 1996), and PV.1-EnR were linearized and
used for in vitro synthesis of capped mRNA using a transcription
kit according to the manufacturer’s instructions (Ambion, Austin,
TX). The synthetic RNAs were quantitated by ethidium bromide
staining in comparison with a standard RNA, and equal transla-
tional efficiency was confirmed using a reticulocyte lysate system.
All data shown in this paper are from individual experiments;
however, in all cases the results were confirmed in multiple
independent trials.
Embryo injection and explant culture. Xenopus laevis em-
bryos were obtained by in vitro fertilization after induction of
females with 500 units of human chorionic gonadotropin. Devel-
opmental stages were designated according to Nieuwkoop and
Faber (1967). RNAs were injected into the two animal blastomeres
of the two-cell-stage embryos or one of the two LMZs or the VMZ
of the four-cell-stage embryos. The injected embryos were allowed
s of reproduction in any form reserved.
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354 Xu et al.to develop to tailbud stage for morphological observation and
whole-mount immunostaining assays. In some experiments, ani-
mal caps were dissected from the injected embryos at stages 8.5 to
9, while VMZ tissues were dissected at stage 10. Both explants
were cultured until early gastrula (stage 11) or tailbud (stage 30)
stage, and harvested for reverse transcription-PCR (RT-PCR) anal-
ysis.
Whole-mount immunostaining. Whole-mount immunostain-
ing of embryos was performed as described previously (Hemmati-
Brivanlou et al., 1989). Globin was detected with the antibody
5.41 (Maeno et al., 1994). Somite muscle was detected with the
ntibody 12/101 (Developmental Studies Hybridoma Bank, Univer-
ity of Iowa). Secondary antibodies conjugated with alkaline phos-
hatase (stained purple) were used.
RT-PCR. Total RNA was extracted from cultured explants
ith TRIzol reagent (GIBCO Bethesda Research Laboratories, Be-
hesda, MD), according to the manufacturer’s instructions, and
ubsequently digested with DNase to remove genomic DNA.
T-PCR was carried out using a Superscript Preamplification
ystem (GIBCO). Primer sets and PCR conditions for Ta-globin,
ATA-2, and EF-1a have been described elsewhere (Zhang and
vans, 1996). The primers for PV.1 are as follows: AAT CAG ATC
CC AGC GCC AC (forward) and CAT GTT GTG CTG CTG GTC
TGT (reverse). The annealing temperature was 56°C, PCR was
un for 27 cycles.
Western blotting. Eight VMZ explants per group were pooled,
nd lysates equivalent to two explants were subjected to sodium
odecyl sulfate–polyacrylamide gel electrophoresis. Following
lectrophoretic transfer, the nitrocellulose filter was blocked in 5%
ilk and incubated with the anti-a-SM-actin antibody (Sigma, St.
ouis, MO) at dilution of 1:200, followed by incubation with
orseradish peroxidase-conjugated anti-mouse IgG antibodies at
ilution of 1:1,000, and visualized by an ECL system (Amersham
ife Science, Inc., Arlington Heights, IL).
RESULTS
FGF inhibits and XFD enhances Xenopus blood forma-
tion. To investigate the role of FGF in VBI formation,
mRNA encoding eFGF or b-gal was injected into the VMZ
of four-cell-stage embryos. Some embryos were injected
into one of the two LMZs, where physiologically no blood is
formed, with XFD or b-gal mRNA. The embryos were
llowed to develop to stage 24 and were subjected to
hole-mount immunostaining with the anti-Ta-globin an-
ibody L5.41. Ventral injection of as little as 10 pg of eFGF
FIG. 1. Effect of FGF signal on blood island formation in ventral
4-cell-stage embryos were each injected with 10 pg RNA encoding
mbryos were injected with 2 ng RNA encoding b-gal (E) or XFD (
ssay with the anti-Ta-globin antibody L5.41 (A, B, E, F), and somite
he above RNAs were injected into the two animal blastomeres o
nimal caps were dissected from the injected embryos at stages 8.5
ultured until tailbud stage and harvested for RT-PCR analysis. To
everse transcriptase (named “Embryo” for positive control) or without (
ranscript was detected as an internal control for equal RNA loading.
Copyright © 1999 by Academic Press. All rightRNA dramatically inhibits VBI formation (Fig. 1B) in
omparison with injection of b-gal mRNA (Fig. 1A). Con-
versely, embryos laterally injected with XFD mRNA (2 ng)
show a marked expansion of the VBI (Fig. 1F) in contrast to
embryos injected with b-gal mRNA (Fig. 1E). By whole-
ount immunostaining with the 12/101 antibody, no in-
uction of somite muscle was seen in the ventral mesoderm
f embryos ventrally overexpressing eFGF (Fig. 1D) com-
ared to those expressing b-gal (Fig. 1C).
To confirm these observations we examined the effect of
modulating FGF signaling levels on globin transcription in
VMZ and animal pole explants. Embryos were injected with
mRNA encoding XFD (2 ng), eFGF (10 pg), or b-gal (2 ng)
nto either the animal pole or the VMZ. The injected VMZ
r animal pole explants were excised and cultured until
tage 30. Total RNA was isolated and assayed by RT-PCR
or the expression of globin and EF-1a. EF-1a expression was
easured as an internal control. As shown in Fig. 1G, eFGF
uppresses globin expression in the uninduced animal caps
(low levels of globin have previously been reported to be
present in the Xenopus animal cap; Zhang and Evans, 1996)
as well as in the VMZ. Conversely, expression of XFD in
either the VMZ or the animal cap significantly enhances
globin expression. All of these observations suggest that
active FGF signaling negatively regulates erythropoiesis,
and suppression of the FGF signaling pathway enhances the
VBI formation in the developing Xenopus embryo. Injection
of CSKA-eFGF DNA (10 pg), a construct containing an actin
promoter to drive eFGF transcription after the midblastula
transition (Harland and Misher, 1988), similarly eliminates
globin expression in animal caps or VMZ explants aged to
stage 30 (data not shown). Thus FGF signaling appears to
also function during later stages of development to suppress
erythropoiesis.
FGF inhibits BMP-4-induced erythropoiesis. Since high
levels of BMP-4 signaling are known to specify the eryth-
ropoietic lineage, we next investigated the effect of FGF on
BMP-4-induced erythropoiesis in animal caps. One nano-
gram of BMP-4 mRNA plus ascending amounts of eFGF
mRNA (0.1, 1, and 10 pg) were coinjected into the animal
pole of two-cell-stage embryos. Total RNA was isolated for
analysis by RT-PCR. We assayed expression levels of
GATA-2, globin, and EF-1a. As shown in Fig. 2, GATA-2
derm. (A–F) Whole-mount immunostaining results. The VMZs of
(A, C) or eFGF (B, D). In a separate experiment, the LMZs of some
I was detected at tailbud stage by whole-mount immunostaining
cle was detected by the antibody 12/101 (C, D). (G) RT-PCR results.
2-cell-stage embryos or into the VMZ of the 4-cell-stage embryos.
, while VMZ tissues were dissected at stage 10. Both explants were
NAs from sibling embryos were subject to the RT procedure withmeso
b-gal
F). VB
mus
f the
to 9
tal Rnamed “No RT” for negative control) followed by PCR. The EF-1a
s of reproduction in any form reserved.
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356 Xu et al.and globin are both induced by BMP-4 alone. However, in
combination with increasing levels of eFGF, BMP-4-
induced GATA-2 and globin expression decreases in a
dose-dependent manner. In the presence of 10 pg of eFGF
mRNA, GATA-2 and globin transcripts are undetectable.
Coinjection of XFD (2 ng) with FGF (10 pg) and BMP-4 (1 ng)
rescued the GATA-2 and globin expression. Thus FGF-
mediated suppression of blood formation in the whole
embryo is probably through an interaction with the BMP-
4-stimulated erythroid program.
FGF enhances smooth muscle development while sup-
pressing erythropoiesis. Based on the above observations
we were prompted to investigate what tissue an active FGF
signal might induce in the ventral region of the embryo.
Since FGF is a strong inducer of somite muscle (Kimelman
and Kirschner, 1987), we tested expression of somite
muscle actin in VMZ explants expressing eFGF. We ob-
served no significant change in the transcript levels of
somite muscle actin in VMZs expressing FGF (data not
shown). This is in agreement with the whole-mount immu-
nostaining results (Fig. 1D). Somite muscle is derived from
dorsal mesoderm. We measured the expression levels of
a-smooth muscle actin, a marker of smooth muscle (Saint-
Jeannet et al., 1992). Smooth muscle is derived from lateral
plate mesoderm. As shown in Fig. 3, protein levels of
FIG. 2. Dose-dependent effect of eFGF on BMP-4-mediated tran-
scriptional regulation of genes in animal pole explants. The two
animal blastomeres of two-cell-stage embryos were injected with
BMP-4 RNA (1 ng) alone (lane 2) or BMP-4 RNA plus increasing
amounts of eFGF RNA (0.1, 1, and 10 pg) (lanes 3, 4, and 5). Some
embryos were injected with equal volumes of water as a negative
control (lane 1), while some were injected with XFD RNA (2 ng)
together with BMP-4 and eFGF to rescue the eFGF effect (lane 6).
Animal caps were dissected at stages 8.5 to 9, cultured until stage
11 or 30, and harvested for RT-PCR analysis.
Copyright © 1999 by Academic Press. All righta-smooth muscle actin in VMZ explants were found to be
enhanced by eFGF and inhibited by XFD. The FGF signaling
pathway therefore appears to participate in the dorsal–
ventral patterning of the ventral mesoderm. High levels of
FGF signaling specifically suppress erythroid development
and enhance smooth muscle development, whereas low
levels are causally associated with the enhancement of
erythropoietic mesoderm and reduction of smooth muscle
development.
FGF enhances expression of PV.1, a BMP-4 effector.
Based on the fact that FGF signaling specifically depresses
BMP-4-induced GATA-2 and globin expression and that
XFD enhances transcript levels of these genes, we were
interested in understanding how FGF affects other BMP-4
signaling molecules. We examined the effect of FGF signal-
ing on the expression of PV.1, one of a family of closely
related homeobox genes shown to mediate the ventralizing
effects of BMP-4 signals and to be inducible by BMP-4 (Ault
et al., 1996) but not vice versa (data not shown). PV.1
expression levels were tested in animal caps expressing
BMP-4 plus ascending amounts of FGF. We employed the
cDNA samples from the experiment described in Fig. 2. As
previously observed, BMP-4 induces PV.1 (Ault et al., 1996).
However, in the additional presence of FGF, PV.1 expres-
sion was significantly augmented. In animal caps taken
from embryos coexpressing XFD with BMP-4 and FGF, PV.1
transcript levels returned to that observed in the presence of
BMP-4 alone (Fig. 2). Thus, FGF appears to be able to
enhance BMP-4-induced PV.1 expression while simulta-
neously suppressing GATA-2 expression.
PV.1 negatively regulates specification of the erythroid
lineage. Because PV.1 expression is amplified in the com-
bined presence of BMP-4 and FGF, we investigated whether
PV.1 is involved in FGF-mediated suppression of BMP-4-
induced erythropoiesis. We tested the effect of PV.1 on VBI
FIG. 3. Effect of FGF signal on smooth muscle (sm) actin level in
the ventral mesoderm. RNAs encoding b-gal (2 ng), eFGF (10 pg),
FD (2 ng), or eFGF (10 pg) plus XFD (2 ng) were injected into VMZ
f the 4-cell-stage embryos. VMZ tissues were dissected at stage 10
nd cultured until tailbud stage followed by Western blotting assay
or a-sm actin level. Lysates from a piece of adult Xenopus lungs
ere used as a positive control.formation by injecting mRNA encoding PV.1 or b-gal into
the VMZ of four-cell-stage embryos. At stage 30, embryos
s of reproduction in any form reserved.
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357Effects of FGF and BMP-4 on Blood Formationwere subjected to whole-mount immunostaining with the
anti-Ta-globin antibody L5.41. Embryos ventrally express-
ng PV.1 show no globin staining (Fig. 4B) in comparison
ith those expressing b-gal (Fig. 4A). GATA-2 and globin
transcription was also inhibited by overexpression of PV.1
in the VMZ (Fig. 4C). Conversely, VMZ explants overex-
pressing GATA-2 show reduced PV.1 transcript levels (data
not shown). GATA-2 and PV.1 thus negatively regulate
each other’s expression. Using a dominant-interfering PV.1
construct (PV.1-EnR, see Materials and Methods), we exam-
ined the effect of inhibition of PV.1 on BMP-4-induced
erythroid development. mRNA encoding b-gal, BMP-4, or
MP-4 plus PV.1-EnR was injected into the animal pole of
-cell-stage embryos. Animal caps were explanted at stage 9
nd allowed to develop to stage 11 or 30. Total RNA was
solated from each group of explants and analyzed by
FIG. 4. (A, B) Ventral overexpression of PV.1 inhibits blood island
RNA encoding b-gal (1 ng) (A) or PV.1 (0.5 ng) (B). The injecte
hole-mount immunostaining to detect the VBI with the anti-Ta-g
enes. For 4-cell-stage embryos, RNA encoding b-gal or PV.1 (0.5 ng
ere explanted at stage 10. For 2-cell stage-embryos, RNAs enco
PV.1-EnR (2 ng) were injected into the animal pole and the anima
cultured until early gastrula (stage 11) or tailbud (stage 30) stage aT-PCR for expression of GATA-2, globin, and EF-1a. As
hown in Fig. 4C, GATA-2 expression in response to BMP-4
Copyright © 1999 by Academic Press. All rights increased in the presence of PV.1-EnR. By stage 30,
nhibition of PV.1 results in a dramatic increase in BMP-4-
timulated globin expression. We also observed a signifi-
ant decrease in a-smooth muscle actin expression follow-
ing blockage of PV.1 activity (data not shown). These
findings support a key role for PV.1 in the inhibition of
erythroid development. Furthermore, PV.1 appears to be
required for smooth muscle development although we
observed that overexpression of PV.1 is not sufficient to
induce smooth muscle in VMZ explants.
A model for regulation of erythroid development. All
of the above observations led us to generate a model
describing how FGF signaling might regulate the decision of
ventral mesoderm to form blood downstream of BMP-4 (Fig.
5). As shown before, BMP-4 activates the expression of
several GATA genes (including GATA-2) and a number of
ation. The VMZs of 4-cell-stage embryos were each injected with
bryos were allowed to develop until tailbud stage followed by
antibody L5.41. (C) Effect of PV.1 signal on expression of erythroid
) was injected into the ventral marginal area and the VMZ tissues
b-gal (4 ng), BMP-4 (2 ng) plus b-gal (2 ng), or BMP-4 (2 ng) plus
(AC) tissues were dissected at stages 8.5 to 9. Both explants were
rvested for RT-PCR analysis.form
d em
lobin
each
dingclosely related homeobox genes (of which PV.1 is a mem-
ber). GATA-2 induces erythroid development in the ventral
s of reproduction in any form reserved.
a
b
t
e
o
t
s
h
o
-
t
1
G
1
L
b
e
i
i
t
r
358 Xu et al.mesoderm, whereas the role of the ventralizing homeobox
genes in specification of blood development has not been
clearly addressed. Here we have shown that PV.1 is likely to
play a role in the negative regulation of erythropoiesis. FGF
suppresses the BMP-4-induced erythropoietic program of
gene expression and enhances smooth muscle develop-
ment, at least in part, by stimulating PV.1 and suppressing
GATA-2 expression. In addition, a negative interaction
between PV.1 and GATA-2 presumably further delineates
the region of blood development. Thus, relative levels of
FGF and BMP-4 signaling regulate the decision of ventral
mesoderm to form blood by controlling the relative expres-
sion levels of the downstream transcription factors PV.1
and GATA-2.
DISCUSSION
Morphogens are thought to pattern the early embryo by
specifying a variety of cell fates along a concentration
gradient. In Xenopus, BMP-4 has been shown to be able to
elicit distinct cell responses at different concentrations in
the ventral mesoderm. Increasing levels of BMP-4 signaling
yield more ventral derivatives of mesoderm. At its highest
level, BMP-4 signaling specifies erythroid development.
Graded activity of BMP-4 signaling is thought to be regu-
lated by the antagonizing action of dorsalizing molecules
secreted from the organizer, such as noggin, chordin, and
follistatin, which bind BMP-4 in the extracellular space
thereby interfering with receptor binding (Zimmerman et
al., 1996; Piccolo et al.,1996; Fainsod et al., 1997; Iemura et.
l.,1998). BMP-4 signaling is also controlled intracellularly
FIG. 5. Scheme for effect of interaction between the BMP-4 and
he FGF signaling pathways on embryonic erythropoiesis. Arrows
epresent stimulation, whereas t-bars denote inhibition.y the antagonizing action of a dorsalizing TGFb family
member, activin (see Kretschmar and Massague´, 1998).
r
t
Copyright © 1999 by Academic Press. All rightThe dorsal to ventral gradient of BMP-4 signaling is
hought to translate into the specification of distinct lin-
ages by regulating the expression of homeobox genes and
ther transcription factors. Indeed BMP-4 has been shown
o induce a number of GATA-binding and homeobox tran-
cription factors. While many of these transcription factors
ave been shown to mediate the multiple patterning effects
f BMP-4 in the ectoderm and mesoderm, only GATA-1 and
2 have been reported to mediate specification of the ery-
hroid lineage by BMP-4 (Zon et al., 1991; Zhang and Evans,
994, 1996; Walmsley et al., 1994; Kelley et al., 1994;
awantka et al., 1995; Maeno et al., 1996; Ault et al., 1996,
997; Onichtchouk et al., 1996; Schmidt et al., 1996;
adher et al., 1996; Xu et al., 1997; Maeda et al., 1997;
Suzuki et al., 1997). The roles of the majority of other
transcription factors in erythropoiesis have not been eluci-
dated.
FGF plays an important role in the blood development of
adult vertebrates synergizing with hematopoietic cytokines
to stimulate the proliferation of early and committed he-
matopoietic progenitors. However, the role of this growth
factor in specification of the erythroid lineage in the devel-
oping embryo has remained unclear. In the Xenopus em-
bryo, low concentrations of bFGF have been reported to
induce blood-like cells in isolated animal caps; however, no
globin was detected in bFGF-treated animal caps (Green et
al., 1990).
Here we address the role of FGF in the specification of
erythroid mesoderm. We report that expression of XFD in
the LMZ of four-cell-stage embryos results in a dramatic
expansion of the VBI, whereas overexpression of FGF in the
VMZ suppresses the VBI formation. Furthermore, expres-
sion of FGF or XFD is sufficient to similarly modulate
erythroid development in isolated VMZs and animal cap
ectoderm. In addition FGF suppresses BMP-4-induced
erythropoiesis in a dose-dependent fashion.
To determine how the BMP-4 and FGF signaling path-
ways might interact in the decision of ventral mesoderm to
form blood, we examined the roles of GATA-2 and PV.1. We
observed that whereas FGF suppresses BMP-4-induced
GATA-2 expression, it enhances expression of PV.1. In
addition, we observed that PV.1 inhibits erythropoiesis,
whereas expression of the dominant interfering form of
PV.1, PV.1-EnR, enhances blood development. These obser-
vations suggest a model of how FGF signaling might regu-
late the specification of erythroid development downstream
of BMP-4. Through Smad1, BMP-4 activates expression of
GATA-2 and PV.1 (as well as several other related GATA-
inding and homeobox transcription factors). In the pres-
nce of FGF signaling, BMP-4-induced GATA-2 expression
s suppressed, whereas PV.1 is enhanced, resulting in the
nhibition of erythropoiesis.
The spatiotemporal expression patterns of eFGF and FGF
eceptor (Issacs et al., 1992; Musci et al., 1990) agree with
he role of FGF signaling in the ventral blood formation.
s of reproduction in any form reserved.
t
i
s
v
s
X
p
s
e
d
a
F
a
w
p
o
w
d
a
1
a
o
t
e
b
a
e
n
v
r
1
359Effects of FGF and BMP-4 on Blood FormationeFGF is expressed both maternally and zygotically with
transcription reaching maximal levels during the gastrula
stage of development. By whole-mount in situ hybridiza-
ion, Issacs et al. (1992) have shown that eFGF is expressed
n a complete ring around the mesoderm during the gastrula
tage. No asymmetry of eFGF expression along the dorso-
entral axis has been detected. Likewise FGF receptor
eems to be ubiquitously expressed in the early developing
enopus embryo (Musci et al., 1990). Thus the expression
atterns of eFGF and the FGF receptor suggest that the FGF
ignaling pathway is possibly involved in formation of the
rythroid mesoderm as well as other derivatives of meso-
erm. The expression patterns of GATA-2 and PV.1 have
lso been illustrated (Kelly et al., 1994; Ault et al., 1996,
1997). Both genes are broadly expressed throughout the
ventral and lateral mesoderm of gastrula-stage embryos and
are activated immediately downstream of BMP-4. Thus
GATA-2 and PV.1 function at the top of a hierarchically
organized gene cascade activated by BMP-4 which leads to
the expression of cell type-specific structural genes.
GATA-2 leads to erythroid differentiation in the ventral
mesoderm (Kelly et al., 1994) while PV.1 appears to be
required for smooth muscle formation (data not shown) and
inhibitory for erythropoiesis (Fig. 4). We observed an in-
crease of PV.1 and a-smooth muscle actin expression and a
decrease of GATA-2 and globin expression in response to
GF in the ventral mesoderm of the early embryo (Figs. 2
nd 3). Therefore, GATA-1 and PV.1 are regulated by both
BMP-4 and FGF signaling pathways and cospecify erythroid
and smooth muscle development in the ventral mesoderm.
However, we do not rule out other predictions that may
also accommodate the working model (Fig. 5). For example,
the expression of GATA-2 and PV.1 may segregate at late or
postgastrulation stages; eFGF expression may be missing
here globin is expressed. Further studies to address these
ossibilities will lend more credence to this model.
While the model presented here is plausible, involvement
f other transcription factors or different mechanisms is
orthy of exploration. For instance, it will be important to
etermine the role of other GATA factors such as GATA-1
nd other PV.1 homologs such as Xvent-1 (Gawantka et al.,
995), Xvent-2 (Onichtchouk et al., 1995), Xom (Ladher et
l., 1996), and Vox (Schmidt et al., 1996) in the specification
f the erythroid mesoderm. Interestingly, we have observed
hat BMP-4-induced GATA-1 expression is also suppressed
by FGF while both Xvent-1 and Xvent-2 are enhanced (data
not shown). Another homeobox gene known to function
downstream of BMP-4, Msx.1, has been reported to inhibit
globin expression (Maeda et al., 1997). Detailed analysis of
the roles of these transcription factors as well as their
interactions with one another will be central to understand-
ing how BMP-4 and FGF interact to regulate specification of
the multiple mesodermal lineages.In contrast to our results, FGF, like BMP-4, has long been
thought to induce blood formation together with other
Copyright © 1999 by Academic Press. All rightventral mesoderm derivatives in animal caps, although no
evidence has ever been shown that it induces globin like
BMP-4. Recently Mead et al. (1998) reported that 50 ng/ml
bFGF induces a barely detectable level of SCL, an early
rythropoietic marker, whereas expression of XFD did not
lock SCL expression. In contrast, BMP-4 was shown to be
potent inducer of SCL in both animal caps and the intact
mbryo; blocking the BMP-4 signaling with the dominant
egative BMP receptor inhibited SCL expression in the
entral region of the embryo. Since expression of globin in
esponse to FGF has never been demonstrated (Green et al.,
990; Mead et al., 1998), the slight increase of SCL expres-
sion in response to FGF may not be able to overcome the
effects of FGF on expression of GATA-2 and PV.1, which we
have shown to be dramatic. The latter two mediate the
overall suppression of FGF on erythropoiesis. Furthermore,
Elefanty et al. (1997) have reported that mouse embryonic
stem cells null for SCL express normal level of GATA-2,
suggesting that GATA-2 and SCL are regulated indepen-
dently.
At present it is not known how FGF differentially regu-
lates transcription factors downstream of BMP-4. Recently,
it has been reported that FGF-like mitogenic growth factors
which signal via receptor tyrosine kinases and the Erk MAP
kinase pathway, such as epidermal growth factor (EGF) or
hepatocyte growth factor, rapidly induce phosphorylation
of Smad1 at multiple serines in the middle of the protein
(Kretzschmar et al., 1997). This phosphorylation is cata-
lyzed directly by the Erk MAP kinases in vitro and in vivo
and leads to the inhibition of Smad1 nuclear translocation.
Erk MAP kinases are also activated by FGF signaling during
mesoderm induction (LaBonne et al., 1995; Umbhauer et
al., 1995). It is of great interest to identify whether FGF also
phosphorylates the middle domain of Smad1 via Erk MAP
kinases, thus antagonizing BMP-4 activity.
In support of our findings, there are a number of cases in
which tyrosine kinase receptor activators and BMPs oppose
each other’s actions during organ development. FGF op-
poses the antiproliferative effect of BMP-2 during limb bud
outgrowth (Niswander and Martin, 1993) and the ability of
BMP-4 to induce interdigital membrane apoptosis during
digit formation (Ganan et al., 1996). EGF can oppose BMP-2
induction of osteogenic differentiation markers (Bernier and
Goltzman, 1992). BMP-2 and BMP-4 can counteract the
induction by FGF of genes essential for tooth development
(Neubu¨ser et al., 1997). Therefore, antagonism between
BMP and FGF signals might be a general phenomenon
controlling cell fate in many tissues.
ACKNOWLEDGMENTS
We thank Dr. Igor Dawid and the National Institute of Child
Health and Human Development for financial support for part of
this project and Dr. Igor Dawid for critically reading the manu-
script. We also appreciate Dr. E. Amaya for the pSP64T-XFD, Dr.
s of reproduction in any form reserved.
BG
G
G
360 Xu et al.H. V. Isaacs for the pSP64T-eFGF and CSKA-eFGF, and Mrs. Annie
Rogers for editing the manuscript. This work was supported with
federal funds from the National Cancer Institute, National Insti-
tutes of Health, under Contract N01-CO-56000 and by the Shiff-
man Program for Clinical and Basic Research between Bar Ilan
University of Israel and the National Cancer Institute of the United
States. The content of this publication does not necessarily reflect
the views or policies of the Department of Health and Human
Services, nor does mention of trade names, commercial products,
or organizations imply endorsement by the U.S. Government.
REFERENCES
Amaya, E., Musci, T. J., and Kirschner, M. W. (1991). Expression of
a dominant negative mutant of the FGF receptor disrupts meso-
derm formation in Xenopus embryos. Cell 66, 257–270.
Ault, K. T., Dirksen, M. L., and Jamrich, M. (1996). A novel
homeobox gene PV.1 mediates induction of ventral mesoderm in
Xenopus embryos. Proc. Natl. Acad. Sci. USA 93, 6415–6420.
Ault, K. T., Xu, R-H., Kung, H-f., and Jamrich, M. A. (1997). The
homeobox gene PV.1 mediates specification of the prospective
neural ectoderm in Xenopus embryos. Dev. Biol. 192, 162–171.
Badiani, P., Corbella, P., Kioussis, D., Marvel, J., and Weston, K.
(1994). Dominant interfering alleles define a role for c-Myb in
T-cell development. Genes Dev. 8, 770–782.
Bernier, S. M., and Goltzman, D. (1992). Effect of protein and
steroidal osteotropic agents on differentiation and epidermal
growth factor-mediated growth of the CFK1 osseous cell line.
J. Cell. Physiol. 152, 317–327.
rivanlou, A. H., and Harland, R. M. (1989). Expression of an
engrailed-related protein is induced in the anterior neural ecto-
derm of early Xenopus embryos. Development 106, 611–617.
Dale, L., Howes, G., Price, B. M., and Smith, J. C. (1992). Bone
morphogenetic protein 4: A centralizing factor in early Xenopus
development. Development 115, 573–585.
Dale, L., and Slack, J. M. (1987). Fate map for the 32-cell stage of
Xenopus laevis. Development 99, 527–551.
Dosch, R., Gawantka, V., Delius, H., Blumenstock, C., and Niehrs,
C. (1997). Bmp-4 acts as a morphogen in dorsoventral mesoderm
patterning in Xenopus. Development 124, 2325–2334.
Elefanty, A. G., Robb, L., Birner, R., and Begley, C. G. (1997).
Hematopoietic-specific genes are not induced during in vitro
differentiation of scl-null embryonic stem cells. Blood 90, 1435–
1447.
Fainsod, A. H., Deibler, K., Yelin, R., Maron, K., Epstein, M.,
Pillemer, G., Steinbeisser, H., and Blum, M. (1997). The dorsal-
izing and neural inducing gene follistatin is an antagonist of
BMP-4. Mech. Dev. 63, 39–50.
Ganan, Y., Macias, D., Duterque-Coquilland, M., Ros, M. A., and
Hurle, J. M. (1996). Role of TGFbs and BMPs as signals control-
ling the position of the digits and the areas of interdigital cell
death in the developing chick limb antopod. Development 122,
2349–2357.
awantka, V., Delius, H., Hirschfeld, K., Blumenstock, C., and
Niehrs, C. (1995). Antagonizing the Spemann organizer: Role of
the homeobox gene Xvent-1. EMBO J. 14, 6268–6279.
raff, J. M., Thies, R. S., Song, J. J., Celeste, A. J., and Melton, D. A.
(1994). Studies with a Xenopus BMP receptor suggest that ventral
mesoderm-inducing signals override dorsal signals in vivo. Cell
79, 169–179.
Copyright © 1999 by Academic Press. All rightreen, J. B., Howes, G., Symes, K., Cooke, J., and Smith, J. C.
(1990). The biological effects of XTC-MIF: Quantitative compari-
son with Xenopus bFGF. Development 108, 173–183.
Harland, R., and Misher, L. (1988). Stability of RNA in developing
Xenopus embryos and identification of a destabilizing sequence
in TFIIIA messenger RNA. Development 102, 341–359.
Hawley, S. H., Wunnenberg-Stapleton, K., Hashimoto, C., Laurent,
M. N., Watabe, T., Blumberg, B. W., and Cho, K. W. (1995).
Disruption of BMP signals in embryonic Xenopus ectoderm leads
to direct neural induction. Genes Dev. 9, 2923–2935.
Holley, S. A., Neul, J. L., Attisano, L., Wrana, J. L., Sasai, Y.,
O’Connor, M. B., DeRobertis, E. M., and Ferguson, E. L. (1996).
The Xenopus dorsalizing factor noggin ventralizes Drosophila
embryos by preventing DPP from activating its receptor. Cell 86,
607–617.
Iemura, S., Yamamoto, T. S., Takagi, C., Uchigama, H., Natsume,
T., Shimasaki, S., Sugino, H., and Ueno, N. (1998). Direct binding
of follistatin to a complex of bone morphogenetic protein and its
receptor inhibits ventral and epidermal cell fates in early Xeno-
pus embryo. Proc. Natl. Acad. Sci. USA 95, 9337–9342.
Jones, C. M., Lyons, K. M., Lapan, P. M., Wright, C. V., and Hogan,
B. L. (1992). DVR-4 (bone morphogenetic protein-4) as a
posterior-ventralizing factor in Xenopus mesoderm induction.
Development 115, 639–647.
Kelley, C., Yee, K., Harland, R., and Zon, L. I. (1994). Ventral
expression of GATA-1 and GATA-2 in the Xenopus embryo
defines induction of hematopoietic mesoderm. Dev. Biol. 165,
193–205.
Kimelman, D., and Kirschner, M. (1987). Synergistic induction of
mesoderm by FGF and TGF-beta and the identification of an
mRNA coding for FGF in the early Xenopus embryo. Cell 51,
869–877.
Kretzschmar, M., Doody, J., and Massague´, J. (1997). Opposing BMP
and EGF signaling pathways converge on the TGF-b family
mediator Smad1. Nature 389, 618–622.
Kretzschmar, M., and Massague´, J. (1998). SMADs: Mediators and
regulators of TGF-b signaling. Curr. Opin. Genet. Dev. 8, 103–
111.
Ladher, R., Mohun, T. J., Smith, J. C., and Snape, A. M. (1996). Xom:
A Xenopus homeobox gene that mediates the early effects of
BMP-4. Development 122, 2385–2394.
LeBonne, C., Burke, B., and Whitman, M. (1995). Role of MAP
kinase in mesoderm induction and axial patterning during Xeno-
pus development. Development 121, 1475–1486.
Maeda, R., Kobayashi, A., Sekine, R., Lin, J. J., Kung, H., and
Maeno, M. (1997). Xmsx-I modifies mesodermal tissue pattern
along dorsoventral axis in Xenopus laevis embryo. Development
124, 2553–2560.
Maeno, M., Mead, P. E., Kelley, C., Xu, R.-H. Kung, H.-f., Suzuki,
A., Ueno, N., and Zon, L. I. (1996). The role of BMP-4 and
GATA-2 in the induction and differentiation of hematopoietic
mesoderm in Xenopus laevis. Blood 88, 1965–1972.
Maeno, M., Ong, R. C., Suzuki, A., Ueno, N., and Kung, H.-f. (1994).
A truncated bone morphogenetic protein 4 receptor alters the
fate of ventral mesoderm to dorsal mesoderm: Roles of animal
pole tissue in the development of ventral mesoderm. Proc. Natl.
Acad. Sci. USA 91, 10260–10264.
Mead, P. E., Kelley, C. M., Hahn, P. S., Piedad, O., and Zon., L. I.
(1998). SCL specifies hematopoietic mesoderm in Xenopus em-
bryos. Development 125, 2611–2620.
s of reproduction in any form reserved.
MN
N
N
N
N
P
361Effects of FGF and BMP-4 on Blood FormationMoon, R. T., and Christian, J. L. (1992). Competence modifiers
synergize with growth factors during mesoderm induction and
patterning in Xenopus. Cell 71, 709–712.
usci, T. J., Amaya, E., and Kirschner, M. W. (1990). Regulation of
the fibroblast growth factor receptor in early Xenopus embryos.
Proc. Natl. Acad. Sci. USA 87, 8365–8369.
eubu¨ser, A., Peters, H., Balling, R., and Martin, G. R. (1997).
Antagonistic interactions between FGF and BMP signaling path-
ways: A mechanism for positioning the sites of tooth formation.
Cell 90, 247–255.
ieuwkoop, P. D. (1969a). The formation of the mesoderm in
urodelean amphibians. I. Induction by the endoderm. Roux’s
Arch. Entw. Mech. Org. 162, 341–373.
ieuwkoop, P. D. (1969b). The formation of the mesoderm in
urodelean amphibians. II. The origin of the dorso-ventral polarity
of the mesoderm. Roux’s Arch. Entw. Mech. Org. 163, 298–315.
ieuwkoop, P. D., and Faber, J. (1967). “Normal Table of Xenopus
Development (Daudin).” North-Holland, Amsterdam.
iswander, L., and Martin, G. R. (1993). FGF-4 and BMP-2 have
opposite effects on limb growth. Nature 361, 68–71.
Onichtchouk, D., Gawantka, V., Dosch, R., Delius, H., Hirschfeld,
K., Blumenstock, C., and Niehrs, C. (1996). The Xvent-2 ho-
meobox gene is part of the BMP-4 signalling pathway controlling
dorsoventral patterning of Xenopus mesoderm. Development
122, 3045–3053.
iccolo, S., Sasai, Y., Lu, B., and De Robertis, E. M. (1996).
Dorsoventral patterning in Xenopus: Inhibition of ventral signals
by direct binding of chordin to BMP-4. Cell 86, 589–598.
Saint-Jeannet, J.-P., Levi, G., Girault, J.-M., Koteliansky, V., and
Thiery, J.-P. (1992). Ventrolateral regionalization of Xenopus
laevis mesoderm is characterized by the expression of alpha-
smooth muscle actin. Development 115, 1165–1173.
Sasai, Y., Lu, B., Steinbeisser, H., Geissert, D., Gont, L. K., and De
Robertis, E. M. (1994). Xenopus chordin: A novel dorsalizing
factor activated by organizer-specific homeobox genes. Cell 79,
779–790.
Schmidt, J. E, von Dassow, G., and Kimelman, D. (1996). Regulation
of dorsal–ventral patterning: The ventralizing effects of the novel
Xenopus homeobox gene Vox. Development 122, 1711–1721.
Slack, J. M. (1994). Inducing factors in Xenopus early embryos.
Curr. Biol. 4, 116–126.
Smith, W. C., and Harland, R. M. (1992). Expression cloning of
noggin, a new dorsalizing factor localized to the Spemann orga-
nizer in Xenopus embryos. Cell 70, 829–840.
Copyright © 1999 by Academic Press. All rightSteinbeisser, H., Fainsod, A., Niehrs, C., Sasai, Y., and De Robertis,
E. M. (1995). The role of gsc and BMP-4 in dorsal–ventral
patterning of the marginal zone in Xenopus: A loss-of-function
study using antisense RNA. EMBO J. 14, 5230–5243.
Suzuki, A., Thies, R. S., Yamaji, N., Song, J. J., Womey, J. M.,
Murakami, K., and Ueno, N. (1994). A truncated bone morpho-
genetic protein receptor affects dorsal–ventral patterning in the
early Xenopus embryo. Proc. Natl. Acad. Sci. USA 91, 10255–
10259.
Suzuki, A., Ueno, N., and Hemmati-Brivanlou, A. (1997). Xenopus
msx1 mediates epidermal induction and neural inhibition by
BMP-4. Development 124, 3037–3044.
Umbhauer, M., Marshall, C. J., Mason, C. S., Old, R. W., and Smith,
J. C. (1995). Mesoderm induction in Xenopus caused by activa-
tion of MAP kinase. Nature 376, 58–62.
Walmsley, M. E., Guille, M. J., Bertwistle, D., Smith, J. C., Pizzey,
J. A., and Patient, R. K. (1994). Negative control of Xenopus
GATA-2 by activin and noggin with eventual expression in
precursors of the ventral blood islands. Development 120, 2519–
2529.
Xu, R.-H., Kim, J., Taira, M., Lin, J.-J., Zhang, C.-h., Sredni, D.,
Evans, T., and Kung, H.-f. (1997). Differential regulation of
neurogenesis by the two Xenopus GATA-1 genes. Mol. Cell. Biol.
17, 436–443.
Zhang, C., and Evans, T. J. (1994). Differential regulation of the two
xGATA-1 genes during Xenopus development. Biol. Chem. 269,
478–484.
Zhang, C., and Evans, T. (1996). BMP-like signals are required after
the midblastula transition for blood cell development. Dev.
Genet. 18, 267–278.
Zimmerman, L. B., De Jesus-Escobar, J. M., and Harland, R. M.
(1996). The Spemann organizer signal noggin binds and inacti-
vates bone morphogenetic protein 4. Cell 86, 599–606.
Zon, L. I., Mather, C., Burgess, S., Bolce, M. E., Harland, R. M., and
Orkin, S. H. (1991). Expression of GATA-binding proteins during
embryonic development in Xenopus laevis. Proc. Natl. Acad.
Sci. USA 88, 10642–10646.
Received for publication August 23, 1998
Revised January 11, 1999
Accepted January 11, 1999
s of reproduction in any form reserved.
